These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 31235535)

  • 41. Droplet Digital PCR for Absolute Quantification of Extracellular MicroRNAs in Plasma and Serum: Quantification of the Cancer Biomarker hsa-miR-141.
    Giraldez MD; Chevillet JR; Tewari M
    Methods Mol Biol; 2018; 1768():459-474. PubMed ID: 29717459
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Droplet digital PCR improves urinary exosomal miRNA detection compared to real-time PCR.
    Wang C; Ding Q; Plant P; Basheer M; Yang C; Tawedrous E; Krizova A; Boulos C; Farag M; Cheng Y; Yousef GM
    Clin Biochem; 2019 May; 67():54-59. PubMed ID: 30905583
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Signature miRNAs in colorectal cancers were revealed using a bias reduction small RNA deep sequencing protocol.
    Sun G; Cheng YW; Lai L; Huang TC; Wang J; Wu X; Wang Y; Huang Y; Wang J; Zhang K; Hu S; Yang JR; Yen Y
    Oncotarget; 2016 Jan; 7(4):3857-72. PubMed ID: 26646696
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Novel circulating microRNAs expression profile in colon cancer: a pilot study.
    Wang YN; Chen ZH; Chen WC
    Eur J Med Res; 2017 Nov; 22(1):51. PubMed ID: 29187262
    [TBL] [Abstract][Full Text] [Related]  

  • 45. High-throughput approaches for microRNA expression analysis.
    Dedeoğlu BG
    Methods Mol Biol; 2014; 1107():91-103. PubMed ID: 24272433
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Study of the preanalytical variables affecting the measurement of clinically relevant free-circulating microRNAs: focus on sample matrix, platelet depletion, and storage conditions.
    Faraldi M; Sansoni V; Perego S; Gomarasca M; Kortas J; Ziemann E; Banfi G; Lombardi G
    Biochem Med (Zagreb); 2020 Feb; 30(1):010703. PubMed ID: 31839723
    [TBL] [Abstract][Full Text] [Related]  

  • 47. microRNA Expression Profiling: Technologies, Insights, and Prospects.
    Roden C; Mastriano S; Wang N; Lu J
    Adv Exp Med Biol; 2015; 888():409-21. PubMed ID: 26663195
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Normalization of circulating microRNA expression data obtained by quantitative real-time RT-PCR.
    Marabita F; de Candia P; Torri A; Tegnér J; Abrignani S; Rossi RL
    Brief Bioinform; 2016 Mar; 17(2):204-12. PubMed ID: 26238539
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Normalization strategies differently affect circulating miRNA profile associated with the training status.
    Faraldi M; Gomarasca M; Sansoni V; Perego S; Banfi G; Lombardi G
    Sci Rep; 2019 Feb; 9(1):1584. PubMed ID: 30733582
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Identification of extracellular miRNA in archived serum samples by next-generation sequencing from RNA extracted using multiple methods.
    Gautam A; Kumar R; Dimitrov G; Hoke A; Hammamieh R; Jett M
    Mol Biol Rep; 2016 Oct; 43(10):1165-78. PubMed ID: 27510798
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Circulating MicroRNAs in Cancer.
    O'Brien KP; Ramphul E; Howard L; Gallagher WM; Malone C; Kerin MJ; Dwyer RM
    Methods Mol Biol; 2017; 1509():123-139. PubMed ID: 27826923
    [TBL] [Abstract][Full Text] [Related]  

  • 52. MiR-145 detection in urinary extracellular vesicles increase diagnostic efficiency of prostate cancer based on hydrostatic filtration dialysis method.
    Xu Y; Qin S; An T; Tang Y; Huang Y; Zheng L
    Prostate; 2017 Jul; 77(10):1167-1175. PubMed ID: 28617988
    [TBL] [Abstract][Full Text] [Related]  

  • 53. MicroRNA Isolation by Trizol-Based Method and Its Stability in Stored Serum and cDNA Derivatives.
    Trakunram K; Champoochana N; Chaniad P; Thongsuksai P; Raungrut P
    Asian Pac J Cancer Prev; 2019 Jun; 20(6):1641-1647. PubMed ID: 31244282
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A phenol-free method for isolation of microRNA from biological fluids.
    Zaporozhchenko IA; Morozkin ES; Skvortsova TE; Bryzgunova OE; Bondar AA; Loseva EM; Vlassov VV; Laktionov PP
    Anal Biochem; 2015 Jun; 479():43-7. PubMed ID: 25843265
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Integrating circulating miRNA analysis in the clinical management of lung cancer: Present or future?
    Lampignano R; Kloten V; Krahn T; Schlange T
    Mol Aspects Med; 2020 Apr; 72():100844. PubMed ID: 31959359
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Plasma miRNAs Display Limited Potential as Diagnostic Tools for Endometriosis.
    Nisenblat V; Sharkey DJ; Wang Z; Evans SF; Healey M; Ohlsson Teague EMC; Print CG; Robertson SA; Hull ML
    J Clin Endocrinol Metab; 2019 Jun; 104(6):1999-2022. PubMed ID: 30608536
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Circulating microRNAs in breast cancer: novel diagnostic and prognostic biomarkers.
    Hamam R; Hamam D; Alsaleh KA; Kassem M; Zaher W; Alfayez M; Aldahmash A; Alajez NM
    Cell Death Dis; 2017 Sep; 8(9):e3045. PubMed ID: 28880270
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Circulating miRNAs in nontumoral liver diseases.
    do Amaral AE; Cisilotto J; Creczynski-Pasa TB; de Lucca Schiavon L
    Pharmacol Res; 2018 Feb; 128():274-287. PubMed ID: 29037479
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Genome-wide circulating microRNA expression profiling reveals potential biomarkers for amyotrophic lateral sclerosis.
    Matamala JM; Arias-Carrasco R; Sanchez C; Uhrig M; Bargsted L; Matus S; Maracaja-Coutinho V; Abarzua S; van Zundert B; Verdugo R; Manque P; Hetz C
    Neurobiol Aging; 2018 Apr; 64():123-138. PubMed ID: 29458840
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Circulating microRNA as a Novel Biomarker for Pulmonary Arterial Hypertension Due to Congenital Heart Disease.
    Chen W; Li S
    Pediatr Cardiol; 2017 Jan; 38(1):86-94. PubMed ID: 27837306
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.